Spectrum Investment Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$205K Buy
222
+9
+4% +$9.12K 0.1% 46
2025
Q4
$229K Buy
+213
New +$204K 0.11% 43

Other funds holding LLY

Spectrum Investment Advisors's LLY Position: Q1 2026 in Review

Spectrum Investment Advisors increased its Eli Lilly (LLY) stake by 4.2% in Q1 2026, buying an estimated $9.12K and bringing the position to 222 shares worth $205K. The position accounts for 0.1% of the portfolio, ranked #46.

Spectrum Investment Advisors first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $229K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Spectrum Investment Advisors held 222 shares of Eli Lilly worth $205K as of Q1 2026.
  • Spectrum Investment Advisors bought 9 Eli Lilly shares in Q1 2026, an estimated $9.12K.
  • Eli Lilly made up 0.1% of Spectrum Investment Advisors's portfolio in Q1 2026, its #46 holding.
  • Spectrum Investment Advisors first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • Spectrum Investment Advisors's Eli Lilly position peaked at $229K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Spectrum Investment Advisors's 13F filing for Q1 2026, filed 14 Apr 2026.